ENDO USA, Inc. - NDC products
NDC labeler, manufacturer of drugs and pharmaceuticals
Products with assigned NDCs are displayed. Select the NDC to see product information. Select the Trade Name to see similar products.
NDC | Trade Name | Labeler Name | Deleted | Deleted Date |
---|---|---|---|---|
49884-0010 | ACCOLATE | Par Pharmaceutical Inc. | YES | No later than 2019-06-25 |
49884-0011 | ACCOLATE | Par Pharmaceutical Inc. | YES | No later than 2019-06-25 |
49884-0589 | Accolate | Par Pharmaceutical, Inc. | YES | 2024-04-30 |
49884-0590 | Accolate | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0424 | ALISKIREN | Endo USA, Inc. | NO | |
49884-0425 | ALISKIREN | Endo USA, Inc. | NO | |
49884-0819 | ALOSETRON HYDROCHLORIDE | Par Pharmaceutical, Inc. | YES | No later than 2023-09-14 |
49884-0820 | ALOSETRON HYDROCHLORIDE | Par Pharmaceutical, Inc. | YES | No later than 2023-09-14 |
49884-0110 | Alprazolam | Endo USA, Inc. | NO | |
49884-0111 | Alprazolam | Endo USA, Inc. | NO | |
49884-0213 | Alprazolam | Endo USA, Inc. | NO | |
49884-0214 | Alprazolam | Endo USA, Inc. | NO | |
49884-0353 | Ambrisentan | Par Pharmaceutical, Inc. | YES | 2023-01-31 |
49884-0354 | Ambrisentan | Par Pharmaceutical, Inc. | YES | 2022-12-31 |
49884-0117 | Amiloride Hydrochloride | Endo USA, Inc. | NO | |
49884-0574 | Amlodipine and Valsartan | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0575 | Amlodipine and Valsartan | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0576 | Amlodipine and Valsartan | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0577 | Amlodipine and Valsartan | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0929 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0930 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0931 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0932 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0952 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0953 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0172 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | YES | 2022-05-31 |
49884-0173 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | YES | 2022-05-31 |
49884-0174 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | YES | 2022-05-31 |
49884-0175 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | YES | 2022-05-31 |
49884-0185 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | YES | 2022-05-31 |
49884-0007 | Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg | Endo USA, Inc. | NO | |
49884-0367 | Balsalazide Disodium | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0151 | Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride | Endo USA, Inc. | NO | |
49884-0058 | Bosentan | Par Pharmaceutical, Inc. | YES | 2023-08-31 |
49884-0059 | Bosentan | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0157 | Budesonide | Par Pharmaceutical Inc. | YES | No later than 2017-04-03 |
49884-0501 | Budesonide | Par Pharmaceutical Inc. | YES | No later than 2018-10-01 |
49884-0725 | Buspirone Hydrochloride | Par Pharmaceutical, Inc. | YES | 2022-08-31 |
49884-0673 | Cabergoline | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0161 | CALCITONIN SALMON | Endo USA, Inc. | NO | |
49884-0658 | Candesartan cilexetil | Par Pharmaceutical Inc. | YES | 2025-12-31 |
49884-0659 | Candesartan cilexetil | Par Pharmaceutical Inc. | YES | 2026-04-30 |
49884-0660 | Candesartan cilexetil | Par Pharmaceutical Inc. | YES | 2026-01-31 |
49884-0661 | Candesartan cilexetil | Par Pharmaceutical Inc. | YES | 2025-08-31 |
49884-0662 | Candesartan Cilexetil-Hydrochlorothiazide | Par Pharmaceutical Inc. | YES | No later than 2017-06-30 |
49884-0663 | Candesartan Cilexetil-Hydrochlorothiazide | Par Pharmaceutical Inc. | YES | No later than 2017-06-30 |
49884-0664 | Candesartan Cilexetil-Hydrochlorothiazide | Par Pharmaceutical Inc. | YES | No later than 2017-06-30 |
49884-0265 | Chlordiazepoxide and Amitriptyline HCl | Par Pharmaceutical Inc | YES | No later than 2019-03-18 |
49884-0266 | Chlordiazepoxide and Amitriptyline HCl | Par Pharmaceutical Inc | YES | No later than 2019-03-18 |
49884-0465 | Cholestyramine | Endo USA, Inc. | NO | |
49884-0466 | Cholestyramine | Endo USA, Inc. | NO | |
49884-0238 | CLARITHROMYCIN | Par Pharmaceutical, Inc. | YES | No later than 2019-06-25 |
49884-0701 | Clomiphene Citrate | Par Pharmaceutical, Inc. | YES | 2025-02-28 |
49884-0306 | Clonazepam | Endo USA, Inc. | NO | |
49884-0307 | Clonazepam | Endo USA, Inc. | NO | |
49884-0308 | Clonazepam | Endo USA, Inc. | NO | |
49884-0309 | Clonazepam | Endo USA, Inc. | NO | |
49884-0310 | Clonazepam | Endo USA, Inc. | NO | |
49884-0774 | Clonidine | Par Pharmaceutical, Inc. | YES | No later than 2014-12-22 |
49884-0775 | Clonidine | Par Pharmaceutical, Inc. | YES | No later than 2014-12-22 |
49884-0776 | Clonidine | Par Pharmaceutical, Inc. | YES | No later than 2014-12-22 |
49884-0171 | Colchicine | Endo USA, Inc. | NO | |
49884-0043 | Cyproheptadine Hydrochloride | Par Pharmaceutical Inc. | YES | No later than 2014-12-22 |
49884-0362 | dantrolene sodium | Endo USA, Inc. | NO | |
49884-0363 | dantrolene sodium | Endo USA, Inc. | NO | |
49884-0364 | dantrolene sodium | Endo USA, Inc. | NO | |
49884-0084 | Dexamethasone | Par Pharmaceutical Inc. | YES | 2019-12-31 |
49884-0085 | Dexamethasone | Par Pharmaceutical Inc. | YES | 2019-08-31 |
49884-0086 | Dexamethasone | Par Pharmaceutical Inc. | YES | 2020-02-29 |
49884-0087 | Dexamethasone | Par Pharmaceutical Inc. | YES | 2020-05-31 |
49884-0129 | Dexamethasone | Par Pharmaceutical Inc. | YES | No later than 2017-06-30 |
49884-0373 | Dexamethasone | Par Pharmaceutical Inc. | YES | 2019-12-31 |
49884-0147 | Dexlansoprazole | ENDO USA, Inc. | NO | |
49884-0148 | Dexlansoprazole | ENDO USA, Inc. | NO | |
49884-0048 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | NO | |
49884-0049 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | NO | |
49884-0090 | Dexmethylphenidate Hydrochloride | ENDO USA, Inc. | YES | No later than 2025-03-24 |
49884-0248 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | NO | |
49884-0333 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | NO | |
49884-0339 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | NO | |
49884-0539 | Dexmethylphenidate Hydrochloride | ENDO USA, Inc. | YES | No later than 2025-03-24 |
49884-0546 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | NO | |
49884-0428 | Dexmethylphenidate Hydrochloride Extended-Release | Par Pharmaceuticals, Inc. | NO | |
49884-0430 | Dexmethylphenidate Hydrochloride Extended-Release | Par Pharmaceuticals, Inc. | NO | |
49884-0839 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0840 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0841 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0842 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0843 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0844 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0905 | Diclofenac Potassium | Endo USA, Inc. | NO | |
49884-0935 | Diclofenac Sodium | Par Pharmaceutical Inc | YES | No later than 2021-09-22 |
49884-0494 | DIGOXIN | Par Pharmaceutical Inc. | YES | 2020-08-31 |
49884-0514 | DIGOXIN | Par Pharmaceutical Inc. | YES | 2021-02-28 |
49884-0829 | Diltiazem Hydrochloride Extended Release | Par Pharmaceutical, Inc. | YES | No later than 2019-03-18 |
49884-0830 | Diltiazem Hydrochloride Extended Release | Par Pharmaceutical, Inc. | YES | No later than 2019-03-18 |
49884-0831 | Diltiazem Hydrochloride Extended Release | Par Pharmaceutical, Inc. | YES | No later than 2019-03-18 |
49884-0832 | Diltiazem Hydrochloride Extended Release | Par Pharmaceutical, Inc. | YES | No later than 2019-03-18 |
49884-0771 | Diphenoxylate Hydrochloride and Atropine Sulfate | Par Pharmaceutical, Inc. | YES | No later than 2019-12-28 |
49884-0232 | Donepezil hydrochloride | Par Pharmaceutical, Inc. | YES | 2020-07-31 |
49884-0217 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | YES | 2023-07-31 |
49884-0218 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | YES | 2023-07-31 |
49884-0219 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | YES | 2023-07-31 |
49884-0220 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | YES | No later than 2022-12-30 |
49884-0221 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | YES | 2023-08-31 |
49884-0222 | Doxepin Hydrochloride | Endo USA, Inc. | NO | |
49884-0091 | Doxycycline | Par Pharmaceutical, Inc. | YES | 2020-03-31 |
49884-0092 | Doxycycline | Par Pharmaceutical, Inc. | YES | 2020-03-31 |
49884-0093 | Doxycycline | Par Pharmaceutical, Inc. | YES | 2020-08-31 |
49884-0236 | Doxycycline | Par Pharmaceutical, Inc. | YES | 2020-06-30 |
49884-0305 | Doxycycline | Par Pharmaceutical, Inc. | YES | 2024-02-28 |
49884-0726 | Doxycycline | Par Pharmaceutical, Inc. | YES | 2024-11-30 |
49884-0727 | Doxycycline | Par Pharmaceutical, Inc. | YES | 2024-12-31 |
49884-0186 | Doxylamine Succinate and Pyridoxine Hydrochloride | Endo USA, Inc. | NO | |
49884-0867 | Dronabinol | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0868 | Dronabinol | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0869 | Dronabinol | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0096 | DYNACIN | Par Pharmaceutical, Inc. | YES | No later than 2019-12-28 |
49884-0097 | DYNACIN | Par Pharmaceutical, Inc. | YES | No later than 2019-12-28 |
49884-0098 | DYNACIN | Par Pharmaceutical, Inc. | YES | No later than 2019-12-28 |
49884-0104 | Entecavir | Par Pharmaceutical Inc. | YES | 2017-08-31 |
49884-0105 | Entecavir | Par Pharmaceutical Inc. | YES | 2017-08-31 |
49884-0547 | Entecavir | Par Pharmaceutical, Inc. | YES | No later than 2020-04-01 |
49884-0548 | Entecavir | Par Pharmaceutical, Inc. | YES | No later than 2020-04-01 |
49884-0112 | Estazolam | Par Pharmaceutical Inc. | YES | No later than 2013-09-27 |
49884-0343 | Estazolam | Par Pharmaceutical Inc. | YES | No later than 2013-09-27 |
49884-0276 | Ethacrynic Acid | Par Pharmaceutical, Inc. | YES | 2022-04-30 |
49884-0119 | Everolimus | ENDO USA, Inc. | NO | |
49884-0125 | Everolimus | ENDO USA, Inc. | NO | |
49884-0127 | Everolimus | ENDO USA, Inc. | NO | |
49884-0128 | Everolimus | ENDO USA, Inc. | NO | |
49884-0158 | Everolimus | ENDO USA, Inc. | NO | |
49884-0159 | Everolimus | ENDO USA, Inc. | NO | |
49884-0160 | Everolimus | ENDO USA, Inc. | NO | |
49884-0283 | Everolimus | ENDO USA, Inc. | NO | |
49884-0228 | Ezetimibe | Par Pharmaceutical Inc | YES | 2020-03-31 |
49884-0761 | Fentanyl | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0762 | Fentanyl | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0763 | Fentanyl | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0764 | Fentanyl | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0459 | Fentanyl Citrate | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0460 | Fentanyl Citrate | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0461 | Fentanyl Citrate | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0462 | Fentanyl Citrate | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0463 | Fentanyl Citrate | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0464 | Fentanyl Citrate | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0468 | Fluoxetine | Endo USA, Inc. | NO | |
49884-0872 | FLUOXETINE | Par Pharmaceutical, Inc. | YES | 2021-10-31 |
49884-0335 | fluoxetine hydrochloride | Endo USA, Inc. | NO | |
49884-0336 | fluoxetine hydrochloride | Endo USA, Inc. | NO | |
49884-0734 | Fluoxetine Hydrochloride | Par Pharmaceutical, Inc | YES | 2016-11-30 |
49884-0735 | Fluoxetine Hydrochloride | Par Pharmaceutical, Inc | YES | 2016-12-31 |
49884-0753 | Flutamide | Par Pharmaceutical, Inc. | YES | 2023-08-31 |
49884-0745 | Glipizide | Par Pharmaceutical, Inc. | YES | No later than 2019-03-18 |
49884-0746 | Glipizide | Par Pharmaceutical, Inc. | YES | No later than 2019-03-18 |
49884-0042 | Glycopyrrolate | Endo USA, Inc. | NO | |
49884-0065 | Glycopyrrolate | Endo USA, Inc. | NO | |
49884-0066 | Glycopyrrolate | Endo USA, Inc. | NO | |
49884-0027 | Hydralazine Hydrochloride | Par Pharmaceutical, Inc. | YES | 2018-04-30 |
49884-0028 | Hydralazine Hydrochloride | Par Pharmaceutical, Inc. | YES | 2018-04-30 |
49884-0029 | Hydralazine Hydrochloride | Par Pharmaceutical, Inc. | YES | 2018-04-30 |
49884-0121 | Hydralazine Hydrochloride | Par Pharmaceutical, Inc. | YES | 2018-04-30 |
49884-0235 | Hydrocodone Polistirex and Chlorpheniramine Polisitrex | Par Pharmaceutical Companies Inc | YES | No later than 2017-12-29 |
49884-0724 | Hydroxyurea | Endo USA, Inc. | NO | |
49884-0366 | Ibuprofen and famotidine | ENDO USA, Inc. | NO | |
49884-0054 | Imipramine Hydrochloride | Par Pharmaceutical, Inc. | YES | 2024-01-31 |
49884-0055 | Imipramine Hydrochloride | Par Pharmaceutical, Inc. | YES | 2024-08-31 |
49884-0056 | Imipramine Hydrochloride | Par Pharmaceutical, Inc. | YES | 2024-01-31 |
49884-0009 | Isosorbide Dinitrate | Endo USA, Inc. | NO | |
49884-0020 | Isosorbide Dinitrate | Endo USA, Inc. | NO | |
49884-0021 | Isosorbide Dinitrate | Endo USA, Inc. | NO | |
49884-0022 | Isosorbide Dinitrate | Endo USA, Inc. | NO | |
49884-0556 | Isosorbide Dinitrate | Endo USA, Inc. | NO | |
49884-0239 | Itraconazole | Par Pharmaceutical, Inc. | YES | 2025-07-31 |
49884-0374 | KHEDEZLA Extended-release | Par Pharmaceutical Inc. | YES | No later than 2017-04-03 |
49884-0375 | KHEDEZLA Extended-release | Par Pharmaceutical Inc. | YES | No later than 2017-04-03 |
49884-0122 | Labetalol HCL | Endo USA, Inc. | NO | |
49884-0123 | Labetalol HCL | Endo USA, Inc. | NO | |
49884-0124 | Labetalol HCL | Endo USA, Inc. | NO | |
49884-0484 | Lamotrigine | Endo USA, Inc. | NO | |
49884-0485 | Lamotrigine | Endo USA, Inc. | NO | |
49884-0486 | Lamotrigine | Endo USA, Inc. | NO | |
49884-0487 | Lamotrigine | Endo USA, Inc. | NO | |
49884-0880 | Lamotrigine | Endo USA, Inc. | NO | |
49884-0881 | Lamotrigine | Endo USA, Inc. | NO | |
49884-0882 | Lamotrigine | Endo USA, Inc. | NO | |
49884-0561 | Lamotrigine Extended Release | Endo USA, Inc. | NO | |
49884-0562 | Lamotrigine Extended Release | Endo USA, Inc. | NO | |
49884-0563 | Lamotrigine Extended Release | Endo USA, Inc. | NO | |
49884-0564 | Lamotrigine Extended Release | Endo USA, Inc. | NO | |
49884-0604 | Lamotrigine Extended Release | Endo USA, Inc. | NO | |
49884-0605 | Lamotrigine Extended Release | Endo USA, Inc. | NO | |
49884-0204 | Levetiracetam | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0205 | Levetiracetam | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0902 | Mafenide acetate | Par Pharmaceutical, Inc. | YES | 2025-05-31 |
49884-0034 | Meclizine Hydrochloride | Par Pharmaceutical, Inc. | YES | No later than 2021-12-22 |
49884-0035 | Meclizine Hydrochloride | Par Pharmaceutical, Inc. | YES | No later than 2021-12-22 |
49884-0949 | Megace ES | Par Pharmaceutical, Inc | YES | No later than 2019-10-01 |
49884-0230 | Megestrol Acetate | Par Pharmaceutical, Inc. | YES | 2023-05-31 |
49884-0289 | Megestrol Acetate | Par Pharmaceutical, Inc. | YES | 2024-08-31 |
49884-0290 | Megestrol Acetate | Par Pharmaceutical, Inc. | YES | 2024-12-31 |
49884-0907 | Megestrol Acetate | Endo USA, Inc. | YES | 2024-12-31 |
49884-0922 | mercaptopurine | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0258 | Metaproterenol Sulfate | Par Pharmaceutical, Inc. | YES | 2019-09-30 |
49884-0259 | Metaproterenol Sulfate | Par Pharmaceutical, Inc. | YES | 2019-09-30 |
49884-0640 | Methimazole | Par Pharmaceutical, Inc. | YES | 2024-10-31 |
49884-0641 | Methimazole | Par Pharmaceutical, Inc. | YES | 2024-10-31 |
49884-0685 | Metoclopramide | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0689 | Metoclopramide | Par Pharmaceutical, Inc. | YES | 2023-10-31 |
49884-0404 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | YES | 2019-08-31 |
49884-0405 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | YES | 2019-10-31 |
49884-0406 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | YES | 2019-09-30 |
49884-0407 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | YES | 2016-11-30 |
49884-0825 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | YES | 2021-05-31 |
49884-0826 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | YES | 2021-05-31 |
49884-0827 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | YES | 2021-05-31 |
49884-0828 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | YES | 2021-04-30 |
49884-0814 | Midodrine Hydrochloride | Endo USA, Inc. | NO | |
49884-0849 | Midodrine Hydrochloride | Endo USA, Inc. | NO | |
49884-0874 | Midodrine Hydrochloride | Endo USA, Inc. | NO | |
49884-0511 | Minocycline | Par Pharmaceutical, Inc. | YES | 2024-03-31 |
49884-0512 | Minocycline | Par Pharmaceutical, Inc. | YES | 2023-01-31 |
49884-0513 | Minocycline | Par Pharmaceutical, Inc. | YES | 2024-04-30 |
49884-0256 | Minoxidil | Endo USA, Inc. | NO | |
49884-0257 | Minoxidil | Endo USA, Inc. | NO | |
49884-0534 | Modafinil | Par Pharmaceutical Inc. | YES | 2020-12-31 |
49884-0535 | Modafinil | Par Pharmaceutical Inc. | YES | 2020-08-31 |
49884-0665 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0666 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0667 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0668 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0669 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0670 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | No later than 2019-12-28 |
49884-0833 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | 2018-11-30 |
49884-0834 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | 2019-02-28 |
49884-0835 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | 2018-07-31 |
49884-0836 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | 2019-02-28 |
49884-0837 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | 2018-11-30 |
49884-0838 | Morphine Sulfate | Par Pharmaceutical Inc. | YES | 2019-02-28 |
49884-0195 | Nabumetone | Par Pharmaceutical Inc. | YES | No later than 2015-03-31 |
49884-0196 | Nabumetone | Par Pharmaceutical Inc. | YES | No later than 2015-03-31 |
49884-0649 | Nabumetone | Par Pharmaceutical Inc | YES | No later than 2019-12-28 |
49884-0650 | Nabumetone | Par Pharmaceutical Inc | YES | No later than 2019-12-28 |
49884-0270 | Nascobal | ENDO USA, Inc. | YES | 2026-12-31 |
49884-0984 | Nateglinide | Par Pharmaceutical, Inc. | YES | 2024-09-30 |
49884-0985 | Nateglinide | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0677 | Nifedipine Extended Release | Par Pharmaceutical, Inc. | YES | No later than 2019-12-28 |
49884-0678 | Nifedipine Extended Release | Par Pharmaceutical, Inc. | YES | No later than 2019-12-28 |
49884-0679 | Nifedipine Extended Release | Par Pharmaceutical, Inc. | YES | No later than 2019-12-28 |
49884-0320 | Olanzapine | Par Pharmaceutical, Inc. | YES | 2024-09-24 |
49884-0321 | Olanzapine | Par Pharmaceutical, Inc. | YES | 2024-07-31 |
49884-0322 | Olanzapine | Par Pharmaceutical, Inc. | YES | 2024-09-24 |
49884-0323 | Olanzapine | Par Pharmaceutical, Inc. | YES | 2024-09-24 |
49884-0250 | Olanzapine and Fluoxetine | Endo USA, Inc. | NO | |
49884-0251 | Olanzapine and Fluoxetine | Endo USA, Inc. | NO | |
49884-0252 | Olanzapine and Fluoxetine | Endo USA, Inc. | NO | |
49884-0253 | Olanzapine and Fluoxetine | Endo USA, Inc. | NO | |
49884-0277 | Olanzapine and Fluoxetine | Endo USA, Inc. | NO | |
49884-0786 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | NO | |
49884-0787 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | NO | |
49884-0788 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | NO | |
49884-0789 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | NO | |
49884-0790 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | NO | |
49884-0019 | Omega-3-Acid Ethyl Esters | Par Pharmaceutical, Inc. | YES | 2021-03-31 |
49884-0397 | Omeprazole and Sodium Bicarbonate | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0455 | Omeprazole and Sodium Bicarbonate | Par Pharmaceutical Inc. | YES | No later than 2019-03-18 |
49884-0268 | Omeprazole/Sodium Bicarbonate | Par Pharmaceutical, Inc. | YES | 2023-12-31 |
49884-0269 | Omeprazole/Sodium Bicarbonate | Par Pharmaceutical, Inc. | YES | 2024-11-30 |
49884-0082 | ORAVIG | Par Pharmaceuticals Companies, Inc. | YES | No later than 2013-06-28 |
49884-0301 | Oxandrolone | Par Pharmaceutical, Inc. | YES | 2025-10-31 |
49884-0302 | Oxandrolone | Par Pharmaceutical, Inc. | YES | 2025-10-31 |
49884-0136 | oxycodone hydrochloride | Par Pharmaceutical, Inc. | YES | 2020-12-31 |
49884-0137 | oxycodone hydrochloride | Par Pharmaceutical, Inc. | YES | 2020-12-31 |
49884-0138 | oxycodone hydrochloride | Par Pharmaceutical, Inc. | YES | 2020-12-31 |
49884-0197 | oxycodone hydrochloride | Par Pharmaceutical, Inc. | YES | 2020-12-31 |
49884-0146 | Penicillamine | Endo USA, Inc. | NO | |
49884-0038 | Phenoxybenzamine Hydrochloride | Par Pharmaceutical, Inc. | YES | No later than 2025-03-24 |
49884-0347 | Pimozide | Endo USA, Inc. | NO | |
49884-0348 | Pimozide | Endo USA, Inc. | NO | |
49884-0231 | PRAZIQUANTEL | Endo USA, Inc. | NO | |
49884-0099 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | YES | No later than 2017-12-29 |
49884-0113 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | YES | 2024-09-30 |
49884-0210 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | YES | 2024-09-30 |
49884-0211 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | YES | 2024-09-30 |
49884-0282 | Propranolol Hydrochloride | Par Pharmaceutical, Inc. | YES | No later than 2014-12-22 |
49884-0328 | Propranolol Hydrochloride | Par Pharmaceutical, Inc. | YES | No later than 2014-12-22 |
49884-0329 | Propranolol Hydrochloride | Par Pharmaceutical, Inc. | YES | No later than 2014-12-22 |
49884-0330 | Propranolol Hydrochloride | Par Pharmaceutical, Inc. | YES | No later than 2014-12-22 |
49884-0936 | QUESTRAN | Endo USA, Inc. | NO | |
49884-0937 | QUESTRAN | Endo USA, Inc. | NO | |
49884-0805 | Quetiapine Fumarate Extended Release | Par Pharmaceutical Inc. | YES | 2019-10-31 |
49884-0806 | Quetiapine Fumarate Extended Release | Par Pharmaceutical Inc. | YES | 2019-10-31 |
49884-0807 | Quetiapine Fumarate Extended Release | Par Pharmaceutical Inc. | YES | 2019-09-30 |
49884-0808 | Quetiapine Fumarate Extended Release | Par Pharmaceutical Inc. | YES | 2019-08-31 |
49884-0544 | Ranitidine | Par Pharmaceutical Inc | YES | No later than 2014-12-22 |
49884-0545 | Ranitidine | Par Pharmaceutical Inc | YES | No later than 2019-12-28 |
49884-0071 | RIBASPHERE RibaPak | PAR Pharmaceutical Companies, Inc. | YES | No later than 2015-03-31 |
49884-0338 | RIBASPHERE RibaPak | PAR Pharmaceutical Companies, Inc. | YES | No later than 2015-03-31 |
49884-0340 | RIBASPHERE RibaPak | PAR Pharmaceutical Companies, Inc. | YES | No later than 2015-03-31 |
49884-0212 | Risperidone | ENDO USA, Inc. | NO | |
49884-0311 | Risperidone | ENDO USA, Inc. | NO | |
49884-0315 | Risperidone | ENDO USA, Inc. | NO | |
49884-0401 | Risperidone | ENDO USA, Inc. | NO | |
49884-0402 | Risperidone | ENDO USA, Inc. | NO | |
49884-0403 | Risperidone | ENDO USA, Inc. | NO | |
49884-0578 | Rizatriptan Benzoate | Par Pharmaceutical Inc. | YES | No later than 2017-04-03 |
49884-0579 | Rizatriptan Benzoate | Par Pharmaceutical Inc. | YES | No later than 2017-04-03 |
49884-0580 | Rizatriptan Benzoate | Par Pharmaceutical Inc. | YES | 2018-04-30 |
49884-0581 | Rizatriptan Benzoate | Par Pharmaceutical Inc. | YES | 2018-01-31 |
49884-0260 | Rosuvastatin Calcium | Par Pharmaceutical, Inc. | YES | 2020-06-30 |
49884-0261 | Rosuvastatin Calcium | Par Pharmaceutical, Inc. | YES | 2020-08-31 |
49884-0262 | Rosuvastatin Calcium | Par Pharmaceutical, Inc. | YES | 2020-08-31 |
49884-0263 | Rosuvastatin Calcium | Par Pharmaceutical, Inc. | YES | 2020-06-30 |
49884-0720 | sapropterin dihydrochloride | ENDO USA, Inc. | NO | |
49884-0873 | SAPROPTERIN DIHYDROCHLORIDE | ENDO USA, Inc. | NO | |
49884-0948 | SAPROPTERIN DIHYDROCHLORIDE | ENDO USA, Inc. | NO | |
49884-0006 | Sodium Phenylbutyrate | ENDO USA, Inc. | NO | |
49884-0170 | Sodium Phenylbutyrate | ENDO USA, Inc. | NO | |
49884-0600 | SSD | Par Pharmaceutical Inc. | YES | No later than 2014-12-22 |
49884-0601 | SSD | Par Pharmaceutical Inc. | YES | No later than 2014-12-22 |
49884-0482 | SUMATRIPTAN SUCCINATE | Par Pharmaceutical Inc | YES | 2013-10-05 |
49884-0483 | SUMATRIPTAN SUCCINATE | Par Pharmaceutical Inc | YES | 2013-08-29 |
49884-0516 | Sumatriptan Succinate | Par Pharmaceutical, Inc. | YES | No later than 2013-03-29 |
49884-0732 | SUMYCIN | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0733 | SUMYCIN | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0418 | Testosterone | Par Pharmaceutical, Inc. | YES | 2024-02-28 |
49884-0510 | Testosterone | Par Pharmaceutical, Inc. | YES | 2024-02-28 |
49884-0773 | TIZANIDINE | Par Pharmaceutical, Inc. | YES | 2019-07-31 |
49884-0947 | TIZANIDINE | Par Pharmaceutical, Inc. | YES | No later than 2022-06-28 |
49884-0611 | tizanidine hydrochloride | Par Pharmaceutical, Inc. | YES | 2022-05-31 |
49884-0719 | tizanidine hydrochloride | Par Pharmaceutical, Inc. | YES | 2022-05-31 |
49884-0765 | tizanidine hydrochloride | Par Pharmaceutical, Inc. | YES | 2022-05-31 |
49884-0254 | Tolcapone | Par Pharmaceutical, Inc. | YES | No later than 2021-12-22 |
49884-0768 | Tolvaptan | Endo USA, Inc. | NO | |
49884-0770 | Tolvaptan | Endo USA, Inc. | NO | |
49884-0106 | Torsemide | Par Pharmaceutical Inc | YES | No later than 2017-04-03 |
49884-0107 | Torsemide | Par Pharmaceutical Inc | YES | No later than 2017-04-03 |
49884-0108 | Torsemide | Par Pharmaceutical Inc | YES | No later than 2017-04-03 |
49884-0109 | Torsemide | Par Pharmaceutical Inc | YES | No later than 2017-04-03 |
49884-0821 | TRAMADOL HYDROCHLORIDE | Par Pharmaceutical, Inc. | YES | 2018-10-31 |
49884-0822 | TRAMADOL HYDROCHLORIDE | Par Pharmaceutical, Inc. | YES | 2019-03-31 |
49884-0823 | TRAMADOL HYDROCHLORIDE | Par Pharmaceutical, Inc. | YES | 2019-02-28 |
49884-0946 | Tramadol hydrochloride and acetaminophen | Par Pharmaceutical, Inc. | YES | 2022-01-31 |
49884-0032 | TRANYLCYPROMINE SULFATE | Par Pharmaceutical, Inc. | YES | 2024-11-30 |
49884-0044 | Travoprost Ophthalmic Solution 0.004% | Par Pharmaceutical, Inc. | YES | 2019-10-31 |
49884-0060 | Trientine Hydrochloride | Endo USA, Inc. | NO | |
49884-0412 | Ursodiol | Endo USA, Inc. | NO | |
49884-0413 | Ursodiol | Endo USA, Inc. | NO | |
49884-0155 | Varenicline | ENDO USA, Inc. | NO | |
49884-0156 | Varenicline | ENDO USA, Inc. | NO | |
49884-0944 | Varenicline | ENDO USA, Inc. | NO | |
49884-0358 | VIGABATRIN | ENDO USA, Inc. | NO | |
49884-0303 | ZAFIRLUKAST | Par Pharmaceutical Inc. | YES | 2017-08-31 |
49884-0304 | ZAFIRLUKAST | Par Pharmaceutical Inc. | YES | 2018-02-28 |
49884-0549 | Zafirlukast | Par Pharmaceutical, Inc. | YES | 2024-04-30 |
49884-0554 | Zafirlukast | Par Pharmaceutical, Inc. | YES | 2024-09-30 |
49884-0723 | Zileuton | Par Pharmaceutical, Inc. | YES | 2023-11-30 |
49884-0903 | Zolpidem tartrate | Par Pharmaceutical, Inc. | YES | No later than 2024-12-19 |
49884-0904 | Zolpidem tartrate | Par Pharmaceutical, Inc. | YES | No later than 2024-12-19 |
49884-0898 | Zolpidem tartrate sublingual | ENDO USA, Inc. | NO | |
49884-0899 | Zolpidem tartrate sublingual | ENDO USA, Inc. | NO | |
49884-0324 | Zuplenz | Par Pharmaceutical, Inc. | YES | No later than 2012-12-29 |
49884-0325 | Zuplenz | Par Pharmaceutical, Inc. | YES | No later than 2012-12-29 |
Thank you for choosing Find-A-Code, please Sign In to remove ads.